SEQUENCER
The FDA just rejected an application of psychedelic therapy for PTSD. But MDMA’s time may well come soon.
As many in the health policy world anticipated, the US Food and Drug Administration has dealt Lykos Therapeutics a major setback. The psychedelic mental health company will not earn approval for its MDMA-therapy combo…yet.
Max G. Levy 